Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-169484
Filing Date
2014-04-30
Accepted
2014-04-30 09:24:37
Documents
11
Effectiveness Date
2014-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d676958ddefa14a.htm DEFA14A 34605
2 GRAPHIC g676958naa1a.jpg GRAPHIC 39564
3 GRAPHIC g676958naa1b.jpg GRAPHIC 28616
4 GRAPHIC g676958naa1c.jpg GRAPHIC 3973
5 GRAPHIC g676958naa1d.jpg GRAPHIC 20709
6 GRAPHIC g676958naa1e.jpg GRAPHIC 9661
7 GRAPHIC g676958naa1f.jpg GRAPHIC 2722
8 GRAPHIC g676958naa1g.jpg GRAPHIC 4082
9 GRAPHIC g676958naa1h.jpg GRAPHIC 3363
10 GRAPHIC g676958naa2.jpg GRAPHIC 3961
11 GRAPHIC g676958naa2pg1.jpg GRAPHIC 12379
  Complete submission text file 0001193125-14-169484.txt   215040
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN IDEC INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19311 | Film No.: 14796156
SIC: 2836 Biological Products, (No Diagnostic Substances)